These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6148150)

  • 1. [Electroencephalographic profile of the neuroleptic, zetidoline].
    Zapletálek M; Libiger J; Hanus H; Valach M
    Cesk Psychiatr; 1984 Jun; 80(3):139-42. PubMed ID: 6148150
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies: Part II.
    Saletu B; Grünberger J; Linzmayer L; Dubini A
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):544-51. PubMed ID: 6140228
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of the neuroleptic agent zetidoline in the rat and the dog.
    Assandri A; Perazzi A; Fontanella L; Ferrari P; Ripamonti A; Tarzia G; Tuan G; Martinelli E
    Drug Metab Dispos; 1984; 12(5):635-40. PubMed ID: 6149917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some autonomic blocking properties of zetidoline (DL 308-IT), a novel potential anti-psychotic drug.
    Fosbraey P; Hird MF; Johnson ES
    J Pharm Pharmacol; 1982 Feb; 34(2):127-8. PubMed ID: 6121877
    [No Abstract]   [Full Text] [Related]  

  • 5. [Zetidoline in the treatment of schizophrenia--initial experiences].
    Molcan J; Korínková V; Koníková M; Rakús A; Pribyl R
    Cesk Psychiatr; 1984 Jun; 80(3):143-5. PubMed ID: 6148151
    [No Abstract]   [Full Text] [Related]  

  • 6. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Schizophrenic psychoses: distinct therapeutic advantages of atypical neuroleptics. Serdolect is effective and free of side effects].
    Psychiatr Prax; 1998 Sep; 25(5 Suppl):1-4. PubMed ID: 9802117
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of neuroleptic medications on continuous performance test measures in schizophrenia.
    Epstein JI; Keefe RS; Roitman SL; Harvey PD; Mohs RC
    Biol Psychiatry; 1996 May; 39(10):902-5. PubMed ID: 8860194
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sulpiride: a neuroleptic agent of new generation with unique pharmacological qualities and rather wide range of clinical applications].
    Pawłowski L
    Psychiatr Pol; 1993; 27(2):199-205. PubMed ID: 8104350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropics and their effect on the EKG in children.
    Wolpert A; Farr D
    Dis Nerv Syst; 1975 Aug; 36(8):435-6. PubMed ID: 240650
    [No Abstract]   [Full Text] [Related]  

  • 11. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile.
    Millan MJ; Gobert A; Newman-Tancredi A; Lejeune F; Cussac D; Rivet JM; Audinot V; Adhumeau A; Brocco M; Nicolas JP; Boutin JA; Despaux N; Peglion JL
    J Pharmacol Exp Ther; 2000 Jan; 292(1):38-53. PubMed ID: 10604930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative electroencephalographic frequencies and relative neuroleptic receptor affinities in schizophrenia.
    Small JG; Milstein V; Malloy FW; Miller MJ
    Biol Psychiatry; 1996 Jun; 39(11):986-8. PubMed ID: 9162214
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of neuroleptic drugs on the intellectual and habilitative behaviors of mentally retarded persons.
    Ferguson DG
    Psychopharmacol Bull; 1982 Jan; 18(1):54-6. PubMed ID: 6152871
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipsychotics and QTc interval prolongation.
    White CM
    Conn Med; 2002 Aug; 66(8):461-3. PubMed ID: 12407956
    [No Abstract]   [Full Text] [Related]  

  • 15. REM-latency in neuroleptic drug withdrawal. A case report.
    Van Sweden B
    Acta Psychiatr Belg; 1984; 84(3):235-9. PubMed ID: 6148841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma prolactin levels after long-term neuroleptic treatment.
    Zelaschi NM; Delucchi GA; Rodriguez JL
    Biol Psychiatry; 1996 May; 39(10):900-1. PubMed ID: 8860193
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of concomitant use of neuroleptic drugs and lithium on the erythrocyte/plasma lithium ratio in Iranian patients with bipolar disorder.
    Azizabadi-Farahani M; Mirazi N; Azar M; Farsam H; Dehpour AR
    J Clin Pharm Ther; 1996 Feb; 21(1):3-7. PubMed ID: 8737176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased manganese-superoxide dismutase activity in postmortem brain from neuroleptic-treated psychotic patients.
    Loven DP; James JF; Biggs L; Little KY
    Biol Psychiatry; 1996 Aug; 40(3):230-2. PubMed ID: 8830959
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome: a review of literature].
    Crespo Facorro B; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12,800-mg ziprasidone overdose without significant ECG changes.
    Arbuck DM
    Gen Hosp Psychiatry; 2005; 27(3):222-3. PubMed ID: 15882771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.